Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Survival with first-line bosentan in patients with primary pulmonary hypertension.

McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, Rainisio M, Simonneau G, Rubin LJ.

Eur Respir J. 2005 Feb;25(2):244-9. Erratum in: Eur Respir J. 2005 May;25(5):942.

2.

Bosentan for the treatment of adult pulmonary hypertension.

Dwyer N, Kilpatrick D.

Future Cardiol. 2011 Jan;7(1):19-37. doi: 10.2217/fca.10.114. Review.

PMID:
21174507
3.

Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.

Valerio CJ, Coghlan JG.

Vasc Health Risk Manag. 2009;5:607-19. Epub 2009 Aug 6. Review.

4.

Bosentan.

Chin K, Channick R.

Expert Rev Cardiovasc Ther. 2004 Mar;2(2):175-82. Review.

PMID:
15151466
6.

Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis.

Becattini C, Manina G, Busti C, Gennarini S, Agnelli G.

Thromb Res. 2010 Jul;126(1):e51-6. doi: 10.1016/j.thromres.2010.01.007. Epub 2010 Feb 21. Review.

PMID:
20172593
7.

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.

Chen YF, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JS, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D.

Health Technol Assess. 2009 Oct;13(49):1-320. doi: 10.3310/hta13490. Review.

8.
9.

Bosentan for the treatment of pulmonary arterial hypertension.

Kenyon KW, Nappi JM.

Ann Pharmacother. 2003 Jul-Aug;37(7-8):1055-62. Review.

PMID:
12841819
10.

Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension.

Strange G, Keogh A, Dalton B, Gabbay E.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):253-63. doi: 10.1586/erp.11.26. Review.

PMID:
21671693
11.
12.

End points in pulmonary arterial hypertension: the way forward.

Peacock A, Naeije R, Galié N, Reeves JT.

Eur Respir J. 2004 Jun;23(6):947-53. Review.

13.

[Bosentan: a new pillar in the treatment of pulmonary hypertension?].

Matthes J, Groner F.

Dtsch Med Wochenschr. 2006 May 5;131(18):1031-4. Review. German. No abstract available.

PMID:
16673229
14.
Items per page

Supplemental Content

Write to the Help Desk